Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Takafumi Nobuchi"'
Autor:
Yutaro Kase, Katsuhiro Uzawa, Sho Wagai, Shusaku Yoshimura, Jun-Ichiro Yamamoto, Yuriko Toeda, Megumi Okubo, Keitaro Eizuka, Toshiaki Ando, Takafumi Nobuchi, Kohei Kawasaki, Tomoaki Saito, Manabu Iyoda, Dai Nakashima, Atsushi Kasamatsu, Hideki Tanzawa
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Exosomes are involved in a wide range of biological processes in human cells. Considerable evidence suggests that engineered exosomes (eExosomes) containing therapeutic agents can attenuate the oncogenic activity of human cancer cells. Despi
Externí odkaz:
https://doaj.org/article/9ed74c814c914ce78df8087aa1a83150
Autor:
Sho Wagai, Shusaku Yoshimura, Atsushi Kasamatsu, Tomoaki Saito, Katsuhiro Uzawa, Dai Nakashima, Jun-ichiro Yamamoto, Takafumi Nobuchi, Toshiaki Ando, Keitaro Eizuka, Megumi Okubo, Hideki Tanzawa, Kohei Kawasaki, Manabu Iyoda, Yutaro Kase, Yuriko Toeda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Exosomes are involved in a wide range of biological processes in human cells. Considerable evidence suggests that engineered exosomes (eExosomes) containing therapeutic agents can attenuate the oncogenic activity of human cancer cells. Despite its bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a83c468243d5fab49c423c7f2dc691
https://doaj.org/article/9ed74c814c914ce78df8087aa1a83150
https://doaj.org/article/9ed74c814c914ce78df8087aa1a83150
Autor:
Takafumi Nobuchi, Tomoaki Saito, Atsushi Kasamatsu, Kohei Kawasaki, Ryunosuke Nozaki, Yutaro Kase, Manabu Iyoda, Masayoshi Saito, Takashi Uno, Katsuhiro Uzawa
Publikováno v:
Biochemical and biophysical research communications. 597
Radiotherapy is commonly used to treat oral squamous cell carcinoma (OSCC), and radioresistance is a critical factor resulting in poor outcomes. Several genes have been reported to be therapeutic targets for radioresistance; however, the involvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97df79d64adbd8a5dd5b3ae8ec59e46f
https://pubmed.ncbi.nlm.nih.gov/35134609
https://pubmed.ncbi.nlm.nih.gov/35134609
Autor:
Kohei Kawasaki, Atsushi Kasamatsu, Toshiaki Ando, Tomoaki Saito, Takafumi Nobuchi, Ryunosuke Nozaki, Manabu Iyoda, Katsuhiro Uzawa
Publikováno v:
Cancers; Volume 13; Issue 24; Pages: 6299
Cancers
Cancers, Vol 13, Iss 6299, p 6299 (2021)
Cancers
Cancers, Vol 13, Iss 6299, p 6299 (2021)
Simple Summary The platelet-activating factor receptor (PAFR) is a key molecule that participates in intracellular signaling pathways. It is involved in cancer progression, but the detailed mechanism of its chemosensitivity is unknown. The purpose of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb9975f0c7a2aa40fee34166c50114e
https://doi.org/10.3390/cancers13246299
https://doi.org/10.3390/cancers13246299